currenfan

ADPT at support...short term long

Long
NASDAQ:ADPT   Adaptive Biotechnologies Corporation
ADPT just had a sell off after forming a bearish rising wedge. Pricing just dumped (lined up with the announcement of a new share offering at $40 to raise R&D funds). Pricing has dipped but now has hit an important support level. Should get a decent bounce here. (RSI also shows oversold)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.